South Africa – The Value of a Patent in South Africa (Bayer Intellectual Property GmbH et al v Austell Pharmaceuticals (Pty) Ltd 20 May 2021 CCP
On 20 May 2021, the South African Patents Court confirmed the rights of a patentee in interim interdict proceedings in circumstances where the patent claim included a non-essential integer.
In this matter, and despite the constraints caused by the Covid-19 pandemic, detailed and voluminous affidavit evidence from various parties in different countries and lengthy legal argument, Bayer was able to obtain an interim interdict within less than 4 months of the launch of generic pharmaceutical being sold by the Austel Pharmaceuticals under the brand name, Rezalto. This judgment confirms the value of a valid patent in South Africa and engenders confidence in the functioning of the South African intellectual property, legal and judicial systems.
Source: PDF attached; 20210520 Bayer v Austel – Commissioner of Patents Judgement ZA2007-06238 – 20 May 2021 – OCR
Constitutional Court Delivers Landmark but Incomplete Copyright Ruling. Parliament Must Now Seize the Opportunity to Modernise South Africa’s Copyright Law for the AI Era
JOHANNESBURG — On 26 June 2026, the Constitutional Court of South Africa handed down its long-awaited judgment in Ex Parte President of the Republic of South Africa: In re Constitutionality of the C...
July 13 2026
Newsflash: First-Ever SEP Judgment in Africa – Moroccan Court Interdicts Transsion Smartphone Sales
The Casablanca Trade Court on 6 July 2026 handed down what appears to be Africa’s first standard essential patent (SEP) ruling, interdicting two Transsion Holdings subsidiaries, Tecno Mobile Lim...
July 09 2026
A Slow Burn
The Tobacco Products and Electronic Delivery Systems Control Bill saw additional progress towards the end of June this year. Specifically, the Portfolio Committee on Health adopted a motion of desirab...
July 08 2026

